9,671 results found

Shearman & Sterling and energy trade publication Petroleum Economist co-authored a report detailing the outlook for the global LNG industry's growth prospects, the impact of ...

In the episode, Emanuelson, former Chief M&A Regulatory Counsel and Associate General Counsel for Intel Corporation, examined the role of M&A in industries such as semiconductors and assessed how...

The Federal Trade Commission Bureau of Competition and the U.S. Department of Justice Antitrust Division issued the 38th "Hart-Scott-Rodino Annual Report".

The FTC and the U.S. DOJ's Antitrust Division launched a joint public inquiry aimed at strengthening enforcement against illegal mergers that threaten competition and consumer choice.

An increasing number of M&A transactions each year involve private equity firms.

Check out this white paper on antitrust risks in merger and acquisitions.

In October, the Federal Trade Commission (FTC) unanimously voted to finalize changes to the premerger notification form and rules implementing the Hart-Scott-Rodino (HSR) Act.

In Federal Trade Comm'n v. Sanford Health, No. 1:17-133, 2017 WL 7369054 (D. N.D. Dec. 13, 2017), the court preliminary enjoined the merger of two large physician practices in North Dakota's Bismarck/Mandan market...

Current FTC and DOJ leaders have signaled that negotiated merger remedies remain a viable path to resolving merger investigations. This analysis explores the evolving landscape of U.S. merger review, examining how early engagement strategies and the concept of 'litigating the fix' are reshaping antitrust enforcement dynamics.

The Trump Administration leadership at the U.S. Department of Justice and Federal Trade Commission have announced reforms regarding merger reviews.

How are public affairs strategies reshaping merger advocacy in today's regulatory environment? Managing Partner Jeny Maier and Nat Wood from Rational 360 explore the evolving playbook for strategic communications in M&A deals, examining how lobbying and public affairs intersect with antitrust considerations under current administrations.

The 2015 Venture Capital Report offers an in-depth analysis of, and outlook for, the US and European venture capital markets.

The 2015 IPO market produced 152 IPOs, a disappointing tally that lagged well behind the 244 IPOs in 2014 despite continued strength in the life sciences sector.

The 2016 Venture Capital Report provides an in-depth analysis of, and outlook for, the US and European venture capital markets.

While a down year compared to all-time highs experienced in 2021 and 2022, 2023 represented another strong year in the U.S. venture community based on deal flow and total investments.

This year's Venture Capital Report offers a detailed review of the US venture capital market, including a breakdown of venture financing activity by state, and analyzes key trends shaping the year ahead.

25 Key Lessons Learned From M&A Transactions.